APA (7th ed.) Citation

Burger, J. A., & Buggy, J. J. (2013). Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765). Leukemia & Lymphoma, 54(11), 2385. https://doi.org/10.3109/10428194.2013.777837

Chicago Style (17th ed.) Citation

Burger, Jan A., and Joseph J. Buggy. "Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765)." Leukemia & Lymphoma 54, no. 11 (2013): 2385. https://doi.org/10.3109/10428194.2013.777837.

MLA (9th ed.) Citation

Burger, Jan A., and Joseph J. Buggy. "Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765)." Leukemia & Lymphoma, vol. 54, no. 11, 2013, p. 2385, https://doi.org/10.3109/10428194.2013.777837.